CV Biomarkers, Anticoagulation Management in AFib, and More

Published: Sept. 25, 2018, 1:19 p.m.

Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: CV biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of testosterone therapy on CV events.